tbuckley/cabot-search huggingface dataset:
WED-421 Novel metabolomics-based non-invasive test for pediatric metabolic dysfunction-associated steatohepatitis using data from youth enrolled in NASH CRN studies
Authors: Helaina Huneault, Shrramana Ganesh Sudhakar, Alasdair Gent, Zachery Jarrell, Matthew Ryan Smith, Ajay Jain, Katherine Yates, Brent A. Neuschwander-Tetri, Jeffrey Schwimmer, Stavra Xanthakos, Jean Molleston, Cynthia Behling, Mark Fishbein, Rishikesan Kamaleswaran, Miriam Vos
Journal: Journal of Hepatology (2025)
FRI-087 Immune cell profiling predicts response to AtezolizumabBevacizumab in advanced hepatocellular carcinoma
Authors: Eunho Choi, Ha Seok Lee, Young-Sun Lee, Youngwoo Lee, Yang Jae Yoo, Seong Hee Kang, Sun Young Yim, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
Journal: Journal of Hepatology (2025)
SAT-084 Microscale detection of selenium in liver tissue using laser ablation-inductively coupled plasma time-of-flight mass spectrometry
Authors: Nataliya Rohr-Udilova, Lyndsey Hendriks, Linda Bjorkhem-Bergman, Matthias Pinter, Michael Trauner, Gunda Koellensperger
Journal: Journal of Hepatology (2025)
SAT-091-YI Using patient-led genetics to identify new therapeutic targets in metastatic cholangiocarcinoma
Authors: Paula Olaizola, Mollie Wilson, Nicholas Younger, Kostas Gournopanos, Aleksandra Rozyczko, Andreea Gradinaru, Kyle Davies, Colm O. Rourke, Jesper Andersen, Luke Boulter
Journal: Journal of Hepatology (2025)
FRI-104 Sorafenib plus transarterial chemoembolization versus sorafenib alone in advanced hepatocellular carcinoma (SELECT): a multicenter, phase 3, randomized, controlled trial
Authors: Yan Zhao, Wei Bai, Rong Ding, Nan You, Lin Zheng, Lei Li, Jianbing Wu, Peng Zhang, Wukui Huang, Hui Zhang, Yongjin Zhang, Diwen Zhu, Haiping Li, Jie Yuan, Dongdong Xia, Zhanxin Yin, Yong Lv, Guohong Han
Journal: Journal of Hepatology (2025)
WED-145 Morphomolecular proliferative disease and microvascular invasion characterize PET-CT positive hepatocellular carcinoma cases: a single-center pilot study
Authors: Spyridon Pantzios, Iakovos Vlahos, Antonia Syriha, Ioanna Maria Grypari, Emmanouil Nychas, Nikolaos Ptohis, Despoina Myoteri, Dina Tiniakos, Ioannis Elefsiniotis
Journal: Journal of Hepatology (2025)
Novel Mutation at Cys225 in <i>GNAO1</i>‐Associated Developmental and Epileptic Encephalopathies: Clinical, Molecular, and Pharmacological Profiling of Case Studies
Authors: Yonika A. Larasati, Gonzalo P. Solis, Alexey Koval, Marie‐Céline François‐Heude, Julie Piarroux, Agathe Roubertie, Ruihan Yang, Ying Zhang, Dezhi Cao, Christian M. Korff, Vladimir L. Katanaev
Journal: MedComm (2025)

ABSTRACT GNAO1 ‐associated disorders have a large spectrum of neurological symptoms, from early‐onset developmental and epileptic encephalopathies (DEE) to late‐onset movement disorders. First reported in 2013 and now identified in around 400 cases worldwide, this disease is caused by dominant, mostly de novo missense mutations in GNAO1 , the gene encoding the major neuronal G protein Gαo. Being the immediate transducer of a number of neuronal G protein‐coupled receptors, Gαo plays crucial functions in brain development and physiology. Here, we discover a novel mutation site in GNAO1 , Cys225 mutated to Tyr or Arg in pediatric individuals from France and China (p.(Cys225Tyr) and p.(Cys225Arg), respectively), leading to severe early‐onset DEE. Molecular investigations characterize the novel pathogenic variants as deficient in the interactions with guanine nucleotides and physiological cellular partners of Gαo, with reduced stability and plasma membrane localization and a strong neomorphic interaction with the chaperone Ric8A. Salts of zinc, emerging as a promising targeted therapy for GNAO1 ‐associated disorders, impose a previously unseen effect on the mutant Gαo, accelerating the loss of its ability to interact with guanine nucleotides. Our study, combining clinical, cellular, molecular, and modeling approaches, describes deep insights into molecular etiology and treatment perspectives of the novel form of GNAO1 ‐associated disorders.
TOP-129-YI Perineural invasion drives hilar cholangiocarcinoma progression via epithelial-mesenchymal transition augmented by cancerassociated Schwann cell-derived nerve growth factor inducible (VGF)
Authors: Honghua Zhang, Linwei Guo, Yang Liu, Xiuxian Li, Zhixiao Song, Leibo Xu, Chao Liu
Journal: Journal of Hepatology (2025)
WED-150-YI Cost-effectiveness of ultrasound plus alpha-fetoprotein and biomarker-based strategies for hepatocellular carcinoma surveillance in patients with chronic hepatitis B
Authors: Tanat Saeoui, Chayanis Kositamongkol, Ratthanan Chantrakul, Pimsiri Sripongpun, Naichaya Chamroonkul, Chanon Kongkamol, Pochamana Phisalprapa, Apichat Kaewdech
Journal: Journal of Hepatology (2025)
THU-098 miR-30e-3p/CXCL3 axis predicts early tumor escape in hepatocellular carcinoma patients undergoing sorafenib treatment
Authors: Elisa Monti, Clara Vianello, Ilaria Leoni, Giuseppe Galvani, Sara Marinelli, Giorgia Marisi, Andrea Casadei Giardini, Francesco Foschi, Catia Giovannini, Fabio Piscaglia, Massimo Negrini, Claudio Stefanelli, Laura Gramantieri, Francesca Fornari
Journal: Journal of Hepatology (2025)
THU-106 Macrophage-targeted biodegradable polymer nanocarriers loaded with a cytokine pathway activator effectively suppress orthotopic HCC growth in immune-competent mice
Authors: Hicham El Mard, Patric Komforth, Dominik Siegl, Adrian Hauck, Lutz Nuhn, Redouane Krini, Detlef Schuppan
Journal: Journal of Hepatology (2025)
THU-078 Artificial intelligence-driven prediction of biology-related poor outcome and presence of vascular invasion in hepatocellular carcinoma
Authors: Agavni Mesropian, Tobias Paul Seraphin, Laura Žigutyteè, James Brooks, Ezequiel Mauro, Albert Gris-Oliver, Roser Pinyol, Carla Montironi, Marko van Treeck, Jakob Nikolas Kather, Tom Luedde, Josep Llovet
Journal: Journal of Hepatology (2025)
THU-103-YI Impact of PNPLA3 and TM6SF2 single nucleotide polymorphisms in metabolic dysfunction-associated steatohepatitis-linked hepatocellular carcinoma development in 3D extracellular matrix models
Authors: Giulia Lupo, Maria Castanho Martins, Stephanie Kucykowicz, Ginevra Pistocchi, George Finney, Laura J Pallett, Walid Al-Akkad, Krista Rombouts
Journal: Journal of Hepatology (2025)
THU-090 Glutaminolysis-driven iron accumulation in the liver: a mechanism for aging through Lysosomal dysfunction
Authors: Claudia M. Rejano-Gordillo, Naroa Goikoetxea-Usandizaga, Claudia Gil-Pitarch, Pietro Guerra, Leidy Estefanía Zapata-Pavas, Carolina Conter, Patricia Peña-Sanfelix, Irene González-Recio, Mate Maus, Teresa C Delgado, Isabel Fabregat, Miguel Lafarga, Manuel Serrano, María Luz Martínez-Chantar
Journal: Journal of Hepatology (2025)
THU-385-YI Association between polycystic ovary syndrome, steatotic liver disease in pregnancy, and adverse pregnancy outcomes: results from the prospective fatty liver in pregnancy cohort
Authors: Cecilia Katzenstein, Nina Rodriguez, Ning Ma, Rachel Meislin, Sonam Rosberger, Keith Sigel, Rhoda Sperling, Norah Terrault, Tatyana Kushner
Journal: Journal of Hepatology (2025)
SAT-112 Role of hypoxia on the progression and survival of hepatocellular carcinoma in hypoxia-inducible factor 1 alpha knockout bi- and tri-dimensional in vitro models
Authors: Tania Payo-Serafín, Jennifer Martínez-Geijo, Carolina Méndez-Blanco, Beatriz San-Miguel, Andrés García-Palomo, Juan José Ortiz-de-Urbina, José Luis Mauriz
Journal: Journal of Hepatology (2025)
FRI-101 Viral etiology of hepatocellular carcinoma as an independent determinant of survival for patients receiving tyrosine kinase inhibitor treatment
Authors: Lu Li, Matthew Shing Hin Chung, Rex Wan-Hin Hui, Xianhua Mao, CL Chiang, Man-Fung Yuen, Lung-Yi Mak, Wai-Kay Seto
Journal: Journal of Hepatology (2025)
FRI-117 Impact of sarcopenia on medium-long-term survival of patients with hepatocellular carcinoma treated with lenvatinib
Authors: Lorenzo Lani, Nicola ReggidorI, Matteo Renzulli, Alessandro Granito, Francesco Tovoli, Nicolò Brandi, Luca Ielasi, Selion Haxhi, Giovanni Monaco, Fabio Piscaglia, Maurizio Baldassarre, Paolo Caraceni, Maurizio Biselli
Journal: Journal of Hepatology (2025)
FRI-451 Comparative analysis of NAD+ boosters reveals the role of liver-nerve axis in metabolic health
Authors: Yasmine Liu, Qi Wang, Jonathan Sulc, Wenyu Liu, Angelique Scantlebery, Sylvia Andrzejewski, Karen Smith, Jeffrey Ciavarri, Riekelt Houtkooper, Johan Auwerx
Journal: Journal of Hepatology (2025)
FRI-340-YI Brain dysfunction is ameliorated by alpha 2A adrenergic receptor antagonism in experimental metabolic dysfunction-associated steatotic liver disease through vasodilatory and anti-inflammatory effects
Authors: Anne Catrine Daugaard Mikkelsen, Kristoffer Kjærgaard, Cecilie Bay-Richter, Betina Elfving, Olivia Greenham, Elizaveta Melnikova, Vladimir Matchkov, Karen Louise Thomsen, Rajeshwar Prosad Mookerjee
Journal: Journal of Hepatology (2025)
WED-024 Linking community-based organizations and specialized prescribing pharmacist teams to improve testing and treatment in hard-to-reach hepatitis C-infected groups: the LiveRx experience in Alberta, Canada
Authors: Cari Egan, Chinedu Diribe, Daniyal Khan, Klaudia Zabrzenski, Jaanek Grewal, Colter Young, Irfan Hyder, Mark Swain
Journal: Journal of Hepatology (2025)
THU-112 Proinflammatorycytokines drive peripheral Foxp3high Tregs into tumor sites: a reliable and accessible prognostic biomarker for HCC patients
Authors: Chien-Hao Huang, Tsung-Han Wu, Po-Ting Lin, Wei Teng, Rachel Wen-Juei Jeng, Chun-yen Lin
Journal: Journal of Hepatology (2025)
TOP-130-YI Deep learning derived radiomics with advanced machine learning outperforms clinical biomarkers in predicting outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
Authors: Mathew Vithayathil, Deniz Koku, Claudia Campani, Jean Charles Nault, Olivier Sutter, Nathalie Ganne-Carrié, Eric Aboagye, Rohini Sharma
Journal: Journal of Hepatology (2025)
WED-415-YI The association between non-invasive tests of liver fibrosis and early diastolic dysfunction in patients with metabolic dysfunction-associated steatotic liver disease
Authors: Fabrizio Amato, Angelo Armandi, Alessandro Andreis, Matteo Bellettini, Francesco Lorusso, Kamela Gjini, Martina Marano, Lorenza Vaira, Chiara Rosso, Gian Paolo Caviglia, Marta Guariglia, Eleonora Dileo, Davide Castagno, Gianluca Alunni, Gaetano de Ferrari, Elisabetta Bugianesi
Journal: Journal of Hepatology (2025)
WED-391 LiverPRO to diagnose and monitor liver fibrosis in patients with MASLD and obesity
Authors: Charlotte Wernberg, Peter Andersen, Katrine Lindvig, Lea Ladegaard Grønkjær, Camilla Dalby Hansen, Johanne Kragh Hansen, Nikolaj Torp, Andreas Sand, Søren Overgaard, Mads Israelsen, Aleksander Krag, Maja Thiele, Mette Lauridsen
Journal: Journal of Hepatology (2025)
THU-116 Novel chemotherapy selectively induces double-strand DNA breaks and death in naïve and Cisplatin-resistant cholangiocarcinoma tumours
Authors: Irene Olaizola, Mikel Odriozola, Maitane Asensio, Paula Olaizola, Ivan Rivilla, Amanda Guimaraes, David de Sancho, Xabier Lopez, Pedro Miguel Rodrigues, Francisco Javier Caballero-Camino, Elisa Herraez, Oscar Briz, Laura Izquierdo-Sánchez, Aitziber Eleta Lopez, Alexander M Bittner, Ana Martinez Amesti, Teresa Miranda, Chiara Braconi, Maria Jesus Perugorria, Luis Bujanda, Jose Marin, Fernando Pedro Cossío, Jesus Maria Banales
Journal: Journal of Hepatology (2025)
WED-115 Differential gene expression in hepatocellular carcinoma: a bioinformatic approach to correlate with HIF1A
Authors: Jennifer Martínez-Geijo, Tania Payo-Serafín, Carolina Méndez-Blanco, Beatriz San-Miguel, Andrés García-Palomo, Juan José Ortiz-de-Urbina, José Luis Mauriz
Journal: Journal of Hepatology (2025)
FRI-004 Association between metabolic syndrome and hepatocellular carcinoma in Mongolia: Prevalence and risk factors across different populations
Authors: Munguntsetseg Batkhuu, Nomuunaa Bayarbat, Barkhas Batkhuu, Khandmaa Narantsetseg, Tuvshinjargal Ulziibadrakh, Ganbolor Jargalsaikhan, Oyungerel Lkhagva-Ochir, Baigal Narantuya, Orkhonselenge Davaadamdain, Bekhbold Dashtseren, Purevjargal Bat-Ulzii, Uurtsaikh Baatarsuren, Zolzaya Doljoo, Sumiya Byambabaatar, Enkhnomin Ochirbat, Byambasuren Ochirsum, Sharawdorj Gur, Erdenechuluun Sainbayar, Enkhtuvshin Khorolgarav, Munkhzaya Munkhbaatar, Naranjargal Dashdorj, Badamsuren Mend-Amar, Anujin Batkholboo
Journal: Journal of Hepatology (2025)
THU-520 Improving the outcomes of patients with cirrhosis in a community clinic through the utilization of advanced practice providers and standardized tailored management protocol
Authors: Julian Diaz-Moreno, Ahmed Atalla, Usman Gul, Ayisha Aziz, Fatma Barakat, James Johnson, Anna Marie Hefner, Deanna Oliver, Tarek Hassanein
Journal: Journal of Hepatology (2025)
TOP-331-YI Standalone medical therapy versus early endovascular intervention as the first step in the management of patients with primary Budd-Chiari syndrome: a randomized controlled trial
Authors: Sagnik Biswas, Shekhar Swaroop, Shubham Mehta, Arnav Aggarwal, Sarthak Saxena, Samagra Agarwal, Deepak Gunjan, Shivanand Gamangatti, Shalimar Shalimar
Journal: Journal of Hepatology (2025)
WED-372 Epigenetic biomarkers and methylome-wide association study (MWAS) for non-invasive diagnosis of at-risk MASH from plasma cell-free DNA
Authors: Manal F. Abdelmalek, Anna Mae Diehl, Georgia Karachaliou, Brent A. Neuschwander-Tetri, Soheil Damangir, Hamed Amini, Leila Bazargan, Rohit Loomba
Journal: Journal of Hepatology (2025)
WED-491 Longitudinal validation of the AGA, AASLD and EASL care pathways for metabolic dysfunction-associated steatotic liver disease (masld) in a prospective cohort of individuals with type 2 diabetes
Authors: Veeral Ajmera, Luis Antonio Diaz, Federica Tavaglione, Monica Tincopa, Egbert Madamba, Ricki Bettencourt, Lisa Richards, Rohit Loomba
Journal: Journal of Hepatology (2025)
WED-125 The Liver Frailty Index predicts survival in hepatocellular carcinoma: an australian multicentre prospective cohort study (APriCa study)
Authors: Leo Ye, Karen Waller, Martin Weltman, Simone Strasser, Ken Liu, Geoff McCaughan, Cameron Gofton, Miriam Levy, Jacob George, Mark Danta
Journal: Journal of Hepatology (2025)
WED-136 Proton-pump inhibitors and gut microbiome are associated with survival in patients with hepatocellular carcinoma under immunotherapy
Authors: Marco Sanduzzi Zamparelli, Ruben López-Aladid, Aitor González Amezcua, Elisa Rubio, José Luis Villanueva-Cañas, Ana Matilla, José Luis Lledó, Maria Varela, Mercedes Iñarrairaegui, Christie Perelló, Beatriz Minguez, Neus Llarch, Laura Marquez Perez, Antonio Guerrero, Gemma Iserte, Marta Fortuny, Andrés Castano-Garcia, Laura Carrión, Jordi Rimola, Maria Ángeles García-Criado, Gemma Domenech, Loreto Boix, Josepmaria Argemi, Ferran Torres, Jordi Bruix, Climent Casals-Pascual, María Reig
Journal: Journal of Hepatology (2025)
SAT-445 Sustained improvements in non-invasive biomarkers with the novel glucagon receptor/glucagon-like peptide-1 receptor dual agonist survodutide: longitudinal analysis from a phase 2 trial in people with metabolic dysfunction-associated steatohepatitis and fibrosis
Authors: Mazen Noureddin, Sandra González Maldonado, Guy W. Neff, Eric J. Lawitz, Elisabetta Bugianesi, Quentin M. Anstee, Philip N. Newsome, Vlad Ratziu, Azadeh Hosseini-Tabatabaei, Jörn M. Schattenberg, Naim Alkhouri, Ramy Younes, Arun J. Sanyal, Corinna Schoelch
Journal: Journal of Hepatology (2025)
THU-432 Impact of metabolic dysfunction-associated steatotic liver disease on post-surgical outcomes in HBV-related hepatocellular carcinoma
Authors: Younghyeon Ahn, Ji Won Yang, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Won-Mook Choi
Journal: Journal of Hepatology (2025)
THU-407-YI Assessing muscle function in non-cirrhotic patients with steatotic liver disease : a cross-sectional study
Authors: Guillaume Henin, Alexis Goffaux, Salomé Declerck, Stéphanie André-Dumont, Etienne Pendeville, Maxime Valet, Thierry Lejeune, Géraldine Dahlqvist, Audrey Loumaye, Peter Stärkel, Nicolas Lanthier
Journal: Journal of Hepatology (2025)
WED-399 Metabolic associated steatotic liver disease- related significant and advanced fibrosis’ prevalence in Brazil and the associated accuracy of FIB-4 and vibration-controlled elastography - a national register
Authors: Cristiane Villela-Nogueira, Nathalie Leite, Cristiane Tovo, Mario Álvares-da-Silva, Claudia Alexandra Pontes Ivantes, Cláudia Alves Couto, Giovanni Faria Silva, Helma Pinchemel Cotrim, Edison Parise, Gil Salles, Claudia Regina Cardoso, Ana Carolina Cardoso, Natalia Wajbrot, Claudia Cravo, Claudia Equi, Luis Fernando Ferreria, Muriel Manica, Gabriela Coral, Jose Tadeu Stefano, Isabel Veloso Alves Pereira, Rafael Biesek Novaes, Brian Vinicius Batista Pinheiro Batista Pinheiro, Luciana Faria, Rosangela Rea, Matheus Truccolo Michalczuk, Fernando Romeiro, Leila Priscilla Pinheiro da Silva, Roberto Carvalho-Filho, Marcelo Chagas, Patricia Momoyo Zitelli, Mário Pessoa, Carlos Antonio Rodrigues Terra Filho, Claudia P. Oliveira
Journal: Journal of Hepatology (2025)
FRI-399-YI Impaired hepatocyte autophagy and bile dysregulation as a novel histological and genetic signature in metabolic dysfunction-associated steatotic liver disease patients with early fibrosis
Authors: Lorenzo Nevi, Francesco Valentini, Francesca Terracciani, Luca Andreotti, Francesca Molinaro, Chiara Taffon, Andrea Baiocchini, Francesca Zalfa, Umberto Vespasiani-Gentilucci, Simone Carotti
Journal: Journal of Hepatology (2025)
FRI-084 Real world treatment patterns and outcomes for hepatocellular carcinoma (HCC) patients receiving transarterial chemoembolization (TACE) or transarterial radioembolization (TARE) in the TARGET-HCC registry
Authors: Amit Singal, Sami Mahrus, Aliramazan Jaffer, Heather Morris, Andrea Mospan, Breda Munoz, Katie Kelley
Journal: Journal of Hepatology (2025)
THU-382-YI Exploring the interplay between sarcopenia, liver and cardiovasculardamage in non-cirrhotic MASLD patients: a genetic perspective
Authors: Annalisa Cespiati, Rosa Lombardi, Floriana Santomenna, Giuseppina Pisano, Giovanna Oberti, Cristina Bertelli, Roberta Forlano, Pinelopi Manousou, Grazia Pennisi, Salvatore Petta, Paola Dongiovanni, Anna Ludovica Fracanzani
Journal: Journal of Hepatology (2025)
THU-387 Analysis of body composition in patients with metabolic dysfunction-associated steatotic liver disease and its relationship with liver fibrosis
Authors: Leticia Mariano, Victoria Borba, Gabriel Calgaro, Brian Pinheiro, Rafael Novaes, Evelize Behrens, Carolina Moreira, Rosangela Rea, Claudia Alexandra Pontes Ivantes
Journal: Journal of Hepatology (2025)
TOP-409 Carriage of rare pathogenic APOB variants predispose to severe metabolic-associated steatotic liver disease and hepatocellular carcinoma
Authors: Matteo Mureddu, Serena Pelusi, Oveis Jamialahmadi, Giulia Periti, Luisa Ronzoni, Hadi Eigadeh, Francesco Malvestiti, Marco Saracino, Vittoria Moretti, Vincenzo La Mura, Robertino Dilena, Saleh Alqahtani, Roberta D’Ambrosio, Salvatore Petta, Anna Ludovica Fracanzani, Luca Miele, Umberto Vespasiani Gentilucci, Elisabetta Bugianesi, Daniele Prati, Carolin V. Schneider, Stefano Romeo, Luca Valenti
Journal: Journal of Hepatology (2025)
THU-081 Association of Tcell epitope spreading with the clinical efficacy of HBV-TCR T cell therapy for HBV-related HCC
Authors: Anthony Tan, Shoukit Hang, Adeline Chia, Nicole Tan, Thinesh Krishnamoorthy, Wan Cheng Chow, Regina Wong, Alessandro Sidoli, Lu-en Wai, Antonio Bertoletti
Journal: Journal of Hepatology (2025)
WED-089-YI Development and validation of PSU’s AI-assisted ultrasound (AI- US) algorithm for focal liver lesion detection
Authors: Janthakan Wongsuwan, Teeravut Tubtawee, Nattaphon Wansom, Sitang Nirattisaikul, Sitthichok Chaichulee, Apichat Kaewdech
Journal: Journal of Hepatology (2025)
FRI-493 Conversion from standard-release to prolonged-release tacrolimus mitigates calcineurin-induced nephrotoxicity in patients after liver transplantation
Authors: Maximilian Joseph Brol, Isabella Munske, Iyad Kabar, Frank Erhard Uschner, Michael Praktiknjo, Martin Schulz, Kai-Henrik Peiffer, Florian Rennebaum, Philipp Houben, Andreas Pascher, Hartmut Schmidt, Jonel Trebicka, Tina Schomacher, Anna Hüsing-Kabar
Journal: Journal of Hepatology (2025)
FRI-463-YI Effect of donor and recipient CYP3A5 genotypes on the pharmacokinetics of tacrolimus after liver transplantation
Authors: Ana Pascual-Dapena, Olga Millan, Pablo Ruiz, Gonzalo Crespo, Nerea Sainz, Jessica Aspas, Yilliam Fundora, Olga Morato, Merceè Brunet, Jordi Colmenero
Journal: Journal of Hepatology (2025)
WED-084 Added-value of PET imaging to AFP score in predicting HCC recurrence after liver transplantation
Authors: Alina Pascale, Aimee Bambara Sanon, Cyril Cosse, Rodolphe Sobesky, Eleonora de Martin, Ilias Kounis, Lea Duhaut, Alina Lutu, Bruno Roche, Faouzi Saliba, Philippe Ichaï, Gabriella Pittau, Oriana Ciacio, Daniel Pietrasz, Marc Antoine Allard, René Adam, Daniel Azoulay, Antonio Sa Cunha, Daniel Cherqui, Eric Vibert, Audrey Coilly, Olivier Rosmorduc, Florent Besson, Nicolas Golse
Journal: Journal of Hepatology (2025)
WED-085 Bone mineral density predicts survival in patients with hepatocellular carcinoma and portal vein tumor thrombosis
Authors: Roman Klöckner, Lukas Müller, Lorena Heim, Felix Hahn, Fabian Stöhr, Tilman Emrich, Dirk Graafen, Jan-Peter Grunz, Daniel Pinto dos Santos, Arndt Weinmann, Friedrich Foerster, Jens Mittler, Jens U. Marquardt, Tobias Bäuerle, Aline Mähringer-Kunz
Journal: Journal of Hepatology (2025)
TOP-094-YI Breaking barriers: intensive care admission in patients with advanced HCC on immunotherapy
Authors: Marta Fortuny, Leonardo Gomes da Fonseca, Manon Allaire, Rocío Sánchez, Jean Charles Nault, Massimo Iavarone, Sofia Ridolfo, Sonia Pascual, Raquel Jimeno, Mariona Calvo, Raimon Rifà Fornt, Marco Sanduzzi Zamparelli, Natalia Jimenez-Esquivel, Sarah Mouri, Mercedes Iñarrairaegui, Josepmaria Argemi, Tania Hernáez-Alsina, Jose Enrique Lorenzo-Barreto, Teresa Ferrer, Susana Coll, Angela Lamarca, Juan Ignacio Marin Zuluaga, Enric Reverter, Ana María López, Alberto Lué, Maria Varela, Ana Matilla, Javier Fernández, María Reig
Journal: Journal of Hepatology (2025)
FRI-519 The post-operative recurrence rate is significantly higher in patients with HBV-HCC compared to those with HCV-HCC
Authors: Tsung-Han Wu, Yen-Chun Liu, Rachel Wen-Juei Jeng, Chung-Wei Su, Po-Ting Lin, Wei Teng, Chien-Hao Huang, Chun-Yen Lin
Journal: Journal of Hepatology (2025)
SAT-452 GLP1 agonist and metabolic dysfunction-associated steatohepatitis (MASH): systematic review and meta-analysis
Authors: Ryan YanZhe Lim, Cheng Han Ng, Ethan Kai Jun Tham, Pojsakorn Danpanichkul, Daniel Huang, Daniel Tung, Mark Muthiah
Journal: Journal of Hepatology (2025)
FRI-487 Treatment of grafts not meeting criteria for transplantation with nor-ursodeoxycholic acid during normothermic machine perfusion reduces apoptosis and biliary injury markers
Authors: Jule Dingfelder, Laurin Rauter, David Pereyra, Moriz Riha, Nikolaus Becker, Andreas Salat, Gerd Silberhumer, Thomas Soliman, Gabriela Berlakovich, Dagmar Kollmann, Georg Gyoeri
Journal: Journal of Hepatology (2025)
FRI-516 Impact of comorbidities on liver transplant outcomes: assessing sex-specific differences by using machine learning analysis
Authors: Trinidad Serrano, Luis M. Esteban, Sergio Sabroso, Vega Rodrigalvarez, Rafael Del Hoyo, Rocio Aznar, Miguel Ángel Gómez Bravo, Rosa Martin-Mateos, Alejandra Otero Ferreiro, Marta Guerrero-Misas, Pablo Ruiz, Carolina Almohalla, Valle Cadahía-Rodrigo, Ana Arias, Sonia Pascual, Javier Bustamante, Elena Oton, Luis Cortes Garcia, Itxarone Bilbao, Esther Molina, Ángel Rubín, Jose Ignacio Herrero, Sheila Pereira, Magdalena Salcedo
Journal: Journal of Hepatology (2025)
FRI-483 Adherence to the mediterranean diet and physical activity levels among liver transplant recipients in Greece: relationship to the metabolic syndrome
Authors: Kleoniki Chatzistavridou, Achilleas Triantafyllou, Styliani Vasileiadou, Athanasios Kofinas, Daphne Mavropoulou, Olga Giouleme, Ioannis Goulis, Anna-Bettina Haidich, Georgios Tsoulfas, Emmanouil Sinakos
Journal: Journal of Hepatology (2025)